Pre-hospital suPAR, lactate and CRP measurements for decision-making: a prospective, observational study of patients presenting non-specific complaints.

Milla Jousi, Marja Mäkinen, Johanna Kaartinen, Leena Meriläinen, Maaret Castrén
{"title":"Pre-hospital suPAR, lactate and CRP measurements for decision-making: a prospective, observational study of patients presenting non-specific complaints.","authors":"Milla Jousi,&nbsp;Marja Mäkinen,&nbsp;Johanna Kaartinen,&nbsp;Leena Meriläinen,&nbsp;Maaret Castrén","doi":"10.1186/s13049-021-00964-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the pre-hospital setting, non-urgent patients with non-specific chief complaints pose assessment challenges for the emergency medical systems (EMS). Severely ill patients should be identified among these patients, and unnecessary transport to the emergency department (ED) should be avoided. Unnecessary admissions burden EDs, deplete EMS resources and can even be harmful to patients, especially elderly patients. Therefore, tools for facilitating pre-hospital decision-making are needed. They could be based on vital signs or point-of-care laboratory biomarkers. In this study, we examined whether the biomarker soluble urokinase plasminogen activator receptor (suPAR), either alone or combined with C-reactive protein (CRP) and/or lactate, could predict discharge from the ED and act as a pre-hospital support tool for non-conveyance decision-making.</p><p><strong>Methods: </strong>This was a prospective, observational study of adult patients with normal or near-normal vital signs transported by an EMS to an ED with a code referring to deteriorated general condition. The levels of suPAR, CRP and lactate in the patients' pre-hospital blood samples were analysed. The values of hospitalized patients were compared to those of discharged patients to determine whether these biomarkers could predict direct discharge from the ED.</p><p><strong>Results: </strong>A total of 109 patients (median age: 81 years) were included in the study. Of those, 52% were hospitalized and 48% were discharged from the ED. No statistically significant association was found between suPAR and the ED discharge vs hospitalization outcome (OR: 1.04, 95% CI 0.97-1.13, AUROC: 0.58, 95% CI 0.47-0.69). Adding CRP (AUROC: 0.64, 95% CI 0.54-0.75) or lactate (AUROC: 0.60, 95% CI 0.49-0.71) to the regression models did not improve their diagnostic accuracy. None of the patients with a suPAR value of less than 2 ng/ml were admitted to hospital, while 64% of the patients with a suPAR value of more than 6 ng/ml were hospitalized.</p><p><strong>Conclusion: </strong>Pre-hospital suPAR measurements alone or combined with CRP and/or lactate measurements could not predict the ED discharge or hospital admission of 109 non-urgent EMS patients with non-specific chief complaints and normal or near-normal vital signs.</p>","PeriodicalId":501057,"journal":{"name":"Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine","volume":" ","pages":"150"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520226/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13049-021-00964-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: In the pre-hospital setting, non-urgent patients with non-specific chief complaints pose assessment challenges for the emergency medical systems (EMS). Severely ill patients should be identified among these patients, and unnecessary transport to the emergency department (ED) should be avoided. Unnecessary admissions burden EDs, deplete EMS resources and can even be harmful to patients, especially elderly patients. Therefore, tools for facilitating pre-hospital decision-making are needed. They could be based on vital signs or point-of-care laboratory biomarkers. In this study, we examined whether the biomarker soluble urokinase plasminogen activator receptor (suPAR), either alone or combined with C-reactive protein (CRP) and/or lactate, could predict discharge from the ED and act as a pre-hospital support tool for non-conveyance decision-making.

Methods: This was a prospective, observational study of adult patients with normal or near-normal vital signs transported by an EMS to an ED with a code referring to deteriorated general condition. The levels of suPAR, CRP and lactate in the patients' pre-hospital blood samples were analysed. The values of hospitalized patients were compared to those of discharged patients to determine whether these biomarkers could predict direct discharge from the ED.

Results: A total of 109 patients (median age: 81 years) were included in the study. Of those, 52% were hospitalized and 48% were discharged from the ED. No statistically significant association was found between suPAR and the ED discharge vs hospitalization outcome (OR: 1.04, 95% CI 0.97-1.13, AUROC: 0.58, 95% CI 0.47-0.69). Adding CRP (AUROC: 0.64, 95% CI 0.54-0.75) or lactate (AUROC: 0.60, 95% CI 0.49-0.71) to the regression models did not improve their diagnostic accuracy. None of the patients with a suPAR value of less than 2 ng/ml were admitted to hospital, while 64% of the patients with a suPAR value of more than 6 ng/ml were hospitalized.

Conclusion: Pre-hospital suPAR measurements alone or combined with CRP and/or lactate measurements could not predict the ED discharge or hospital admission of 109 non-urgent EMS patients with non-specific chief complaints and normal or near-normal vital signs.

Abstract Image

Abstract Image

院前suPAR、乳酸和CRP测量对决策的影响:一项提出非特异性投诉的患者的前瞻性观察性研究
背景:在院前环境中,非紧急患者的非特异性主诉对急诊医疗系统(EMS)的评估提出了挑战。应在这些患者中确定重症患者,并应避免不必要的运送到急诊室(ED)。不必要的住院给急诊科造成负担,消耗急诊资源,甚至可能对患者,特别是老年患者造成伤害。因此,需要促进院前决策的工具。它们可以基于生命体征或现场实验室生物标志物。在这项研究中,我们研究了生物标志物可溶性尿激酶纤溶酶原激活剂受体(suPAR),无论是单独使用还是与c反应蛋白(CRP)和/或乳酸盐联合使用,是否可以预测ED的出院,并作为院前非转运决策的支持工具。方法:这是一项前瞻性观察性研究,研究对象是生命体征正常或接近正常的成年患者,由EMS运送到急诊室,编码为一般情况恶化。分析患者院前血液中suPAR、CRP和乳酸水平。将住院患者的值与出院患者的值进行比较,以确定这些生物标志物是否可以预测ed直接出院。结果:共纳入109例患者(中位年龄:81岁)。其中52%住院,48%从急诊科出院。suPAR与急诊科出院与住院结果之间无统计学意义的关联(OR: 1.04, 95% CI 0.97-1.13, AUROC: 0.58, 95% CI 0.47-0.69)。在回归模型中加入CRP (AUROC: 0.64, 95% CI 0.54-0.75)或乳酸盐(AUROC: 0.60, 95% CI 0.49-0.71)并没有提高其诊断准确性。suPAR值低于2 ng/ml的患者没有住院,而suPAR值大于6 ng/ml的患者中有64%住院。结论:院前suPAR测量单独或联合CRP和/或乳酸测量不能预测109例主诉非特异性、生命体征正常或接近正常的非紧急EMS患者的ED出院或住院。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信